氯沙坦钾和依那普利联合治疗Ⅳ期糖尿病肾病的临床观察

目的 观察氯沙坦钾和依那普利联合治疗Ⅳ期糖尿病肾病(DN)的疗效.方法 将74例Ⅳ期DN患者随机分为三组,氯沙坦钾组:口服氯沙坦钾100 mg,1次/d;依那普利组;口服依那普利10 mg,1次/d;联合治疗组:同时服用以上两种药物,且剂量不变.三组患者治疗均在3年以上.监测治疗前后24 h尿蛋白定量及血清肌酐.结果 三组患者24 h尿蛋白定量较治疗前均下降,差异有统计学意义(P＜0.05),联合治疗组效果更好(P＜0.01).血清肌酐仅联合治疗组下降,差异有统计学意义(P＜0.05).结论 联合应用氯沙坦钾和依那普利可以有效控制Ⅳ期DN患者蛋白尿,延缓肾脏病进展.

The clinical observation to the consociation treatment that losartan potassium combined with enalapril used in treating Ⅳ phase diabetic nephropathy

Objective To observe the curative effect that losartan potassium combined with enalapril used in treating Ⅳ phase diabetic nephropathy(DN). Methods Divided 74 Ⅳ phase DN suffers into 3 groups randomly.Losartan group:taken losartan potassium lablets 100 mg once every day orally,enalapril group:taken enalapril tablets 10 mg once every day orally,consociation group:taken the two drugs above ai one time with the same dosage.The treatment in the 3 groups were all above 3 years.monitoring the 24-hour albuminuria and SCr back and forth the treatment.Results It worthed statistics meaning that the 24-hour albuminuria in the 3 groups all declined(P＜0.05).The effect of consociation group did better(P＜O.01).In term of SCr,it declined in the consociation group worthed statisties meaning only.Conclusion The consociation application with losartan potassium and enalapril can control the proteinuria of Ⅳ phage DN suffers efficiently as well as defer process of kidney diseases.